Back | Next |
home / stock / insm / insm message board
Subject | By | Source | When |
---|---|---|---|
Anyone here from the old days? 2008 ish? | Reluctant Observer | investorshub | 09/13/2017 1:00:20 AM |
Wow that`s a lot of cash. More than | blueyedcatch | investorshub | 09/12/2017 2:57:21 AM |
Insmed Announces Closing of Public Offering - https://finance.yahoo.com/news/ins | fireopal | investorshub | 09/11/2017 8:38:19 PM |
$INSM looks higher | tfusari | investorshub | 09/11/2017 7:37:02 PM |
not yet | John Kent | investorshub | 09/08/2017 2:56:43 PM |
Thanks man. Did you take a | Crazyjake27 | investorshub | 09/08/2017 2:27:18 PM |
I am happy for you great work | John Kent | investorshub | 09/08/2017 2:25:30 PM |
I'm out at. 30.25. From 24. | Crazyjake27 | investorshub | 09/08/2017 2:07:58 PM |
I`m wondering how fast, with the new FDA | blueyedcatch | investorshub | 09/08/2017 12:53:39 AM |
good luck hope it works for you | John Kent | investorshub | 09/07/2017 4:49:47 PM |
Trailing stop man. Trying to make some | Crazyjake27 | investorshub | 09/07/2017 4:48:41 PM |
this was pumped up to sell shares good | John Kent | investorshub | 09/07/2017 4:47:16 PM |
After the offering they will have around 450 | Crazyjake27 | investorshub | 09/07/2017 4:46:00 PM |
There is no revenue yet but and approved | Crazyjake27 | investorshub | 09/07/2017 4:43:15 PM |
Nonsense pure nonsense. Its not an FDA approval | John Kent | investorshub | 09/07/2017 4:31:59 PM |
Only around 12 millions shares. This is | Crazyjake27 | investorshub | 09/07/2017 3:29:01 PM |
Plenty of working capital! $INSM is a great | crudeoil24 | investorshub | 09/07/2017 2:34:18 PM |
I TRIED GETTING FILLED | TheFinalCD | investorshub | 09/07/2017 2:33:32 PM |
Heard we got news today | BoilerRoom | investorshub | 09/07/2017 1:13:24 PM |
That`s a lot of cash for? IPLEX? | blueyedcatch | investorshub | 09/07/2017 12:35:18 PM |
News, Short Squeeze, Breakout and More Instantly...
2024-07-12 10:56:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-09 08:00:06 ET Vamil Divan from Guggenheim issued a price target of $95.00 for INSM on 2024-07-09 06:44:00. The adjusted price target was set to $95.00. At the time of the announcement, INSM was trading at $70.05. The overall price target consensus is at $72.91 w...
Additional Positive Data from Pivotal ASPEN Study of Brensocatib in Patients with Bronchiectasis to be Presented at the 7th World Bronchiectasis Conference PR Newswire —New Graph Depicting 52-Week FEV1 Data Illustrate Significantly Less Decline in Lung Function for Bren...